UPTRAVI (SELEXIPAG) HAS BEEN REGISTERED IN THE RUSSIAN FEDERATION FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION IN ADULT PATIENTS

article Editorial

Eurasian heart journal
Evrazijskij kardiologičeskij žurnal

ISSN 2225-1685 (Print)
ISSN 2305-0748 (Online)

User

eng | рус

Eurasian heart journal

Advanced search

Archives

UPTRAVI (SELEXIPAG) HAS BEEN REGISTERED IN THE RUSSIAN FEDERATION FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION IN ADULT PATIENTS

Full Text:

PDF (Rus) | PDF (Eng) |

Generate QR code

About the Author

article Editorial

Review

For citations:

UPTRAVI (SELEXIPAG) HAS BEEN REGISTERED IN THE RUSSIAN FEDERATION FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION IN ADULT PATIENTS. Eurasian heart journal. 2019;(4):162-165.

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0.

ISSN 2225-1685 (Print)
ISSN 2305-0748 (Online)

OOO InterMedservice
Address: 121069, Russia, Moscow, Stolovy Lane, 6
Tel.: +7 (985) 763-98-00
e-mail: og@intermed.services

Registered by the Federal Service for Supervision of Communications, Information Technology and Mass Communications December 28, 2010. Mass media registration certificate No ФС 77-43372.

supported by NEICON (Elpub lab)

Username
Password
	Remember me
Not a user? Register with this site Forgot your password?

User

Eurasian heart journal

UPTRAVI (SELEXIPAG) HAS BEEN REGISTERED IN THE RUSSIAN FEDERATION FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION IN ADULT PATIENTS

Full Text:

About the Author

Review

For citations:

Cookies policy